Lidokain Isdin

Lidocaine, the active ingredient in Lidokain Isdin, is a local anesthetic presented as a topical preparation for cutaneous use. It provides reversible blockade of voltage‑gated sodium channels, producing temporary loss of sensation that facilitates minor skin procedures, superficial pain relief and itching control in adults.

GNH USA supplies Lidokain Isdin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is distributed under strict quality‑assurance protocols, ensuring consistent potency and safety for end‑users.

Lidokain Isdin (lidocaine) is used topically to provide local anesthesia for conditions affecting the skin and superficial tissues.

- Minor skin procedures: provides temporary loss of sensation to facilitate biopsies, suturing, laser therapy or other minor interventions. - Superficial pain: reduces localized pain from minor burns, abrasions, insect bites or postoperative discomfort. - Itching relief: alleviates pruritus associated with allergic reactions, dermatitis or minor irritations.

Lidocaine applied to the skin may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Skin irritation: mild redness or erythema at the application site. - Burning sensation: transient warmth or stinging after application. - Pruritus: mild itching localized to the treated area.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or angioedema indicating hypersensitivity. - Anaphylaxis: rare systemic allergic response requiring immediate medical attention. - Methemoglobinemia: abnormal hemoglobin levels causing cyanosis, especially with extensive use.

When using Lidokain Isdin, several precautions should be observed to minimize risk and ensure effective local anesthesia. - Allergy assessment: verify no known hypersensitivity to lidocaine or other amide‑type local anesthetics. - Application area: limit use to intact, non‑mucosal skin and avoid large surface areas exceeding recommended limits. - Avoid ocular exposure: keep product away from eyes, ears and mucous membranes. - Concomitant anesthetics: do not combine with other topical anesthetics unless directed by a healthcare professional. - Systemic absorption: monitor for signs of toxicity if applied over extensive areas or under occlusion. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lidokain Isdin can interact with other medicines, and awareness of these interactions helps prevent adverse effects.

Major Interactions (Avoid): - Other topical anesthetics: concurrent use may increase risk of local or systemic toxicity. - Intravenous lidocaine or antiarrhythmic agents (e.g., procainamide): additive cardiac effects can lead to arrhythmias. - CYP3A4 inhibitors (e.g., ketoconazole) in high doses: may raise systemic lidocaine levels if significant absorption occurs.

Moderate Interactions (Monitor Closely): - Drugs that lower seizure threshold (e.g., tramadol, bupropion): may augment CNS toxicity signs. - Alcohol consumption: can enhance systemic effects of lidocaine. - Beta‑blockers: may potentiate cardiac depressant effects in case of systemic absorption.